Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TXMD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
TXMD
TherapeuticsMD, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TXMD
TherapeuticsMD, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
TXMD
TherapeuticsMD, Inc.
Change
1.81
▲
+1.69%
Mkt cap
$20.7M
Revenue
$869,000
Q2 FY26
Revenue
$3M
FY25
LLY
ELI Lilly & Co
Change
1,417.65
▲
+0.59%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
TXMD
TherapeuticsMD, Inc.
vs
LLY
ELI Lilly & Co
1.81
▲
+1.69%
Price
1,417.65
▲
+0.59%
$20.7M
Mkt cap
$1.3T
Q2 FY26
$869,000
Revenue
$24.4B
Q3 FY26
FY25
$3M
Revenue
$65.2B
FY25
Change
Change
TXMD
1.81
▲
+1.69%
vs
LLY
1,417.65
▲
+0.59%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
TXMD: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TXMD, solid
LLY, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TXMD
0
None
Shared
0
No disclosed counterparties: TXMD.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR